Han Chu Lee (H C Lee)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 51

Top Topics

Hepatitis B Virus

Prognostic Factors

Radiofrequency Ablation

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Journal of liver cancer

Nature medicine

Journal of gastroenterology and hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine 30 (3) (2024)
Jonggi Choi, Jina Park, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Sujin Kwon, Sang-Hyun Hwang
Improving the hepatitis C virus care cascade with the in-hospital Reflex tEsting ALarm-C (REAL-C) model. Liver international : official journal of the International Association for the Study of the Liver (2024)
Jiwon Yang, Jonggi Choi, Won-Mook Choi, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Jonggi Choi, Jina Park, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Sujin Kwon, Sang-Hyun Hwang
Improving the hepatitis C virus care cascade with the in-hospital Reflex tEsting ALarm-C (REAL-C) model. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Jonggi Choi, Jina Park, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Sujin Kwon, Sang-Hyun Hwang
Improving the hepatitis C virus care cascade with the in-hospital Reflex tEsting ALarm-C (REAL-C) model. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Jiwon Yang, Jonggi Choi, Won-Mook Choi, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC. Liver international : official journal of the International Association for the Study of the Liver (2024)
Jiwon Yang, Jonggi Choi, Won-Mook Choi, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Jiwon Yang, Jonggi Choi, Won-Mook Choi, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine (2024)
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Samuel Chuah, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok Bog Moon, Ki-Hun Kim, Tae Won Kim, David Tai, Valerie Chew, Jeong Seok Lee, Richard S Finn, June Young Koh, Changhoon Yoo
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial. Nature medicine (2024)
Jonggi Choi, Jina Park, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Sujin Kwon, Sang-Hyun Hwang
Improving the hepatitis C virus care cascade with the in-hospital Reflex tEsting ALarm-C (REAL-C) model. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Jiwon Yang, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jonggi Choi
Revisiting the steatosis-associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability. Journal of gastroenterology and hepatology (2024)
Gi-Ae Kim, Yewan Park, Shin Ju Oh, Jooyi Jung, Seungbong Han, Hye-Sook Chang, Sung Won Park, Tae Hyup Kim, Hye Won Park, Jaewon Choe, Jaeil Kim, Han Chu Lee
A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis: HCC prediction for non-cirrhotic NAFLD. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2023)
Hyeyeon Hong, Minjoo Cho, Chaeyeon Lim, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jonggi Choi
Longitudinal changes in renal function in patients with chronic hepatitis B on antiviral treatment. Alimentary pharmacology & therapeutics (2023)
Su Jin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment. Journal of liver cancer 23 (1) (2023)
Su Jin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment. Journal of liver cancer 23 (1) (2023)
Su Jin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment. Journal of liver cancer 23 (1) (2023)
Su Jin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment. Journal of liver cancer 23 (1) (2023)
Hyeyeon Hong, Won-Mook Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jonggi Choi
Prediction of Hepatocellular Carcinoma Development in Korean Patients after Hepatitis C Cure with Direct-Acting Antivirals. Gut and liver (2023)
Gi-Ae Kim, Yewan Park, Shin Ju Oh, Jooyi Jung, Seungbong Han, Hye-Sook Chang, Sung Won Park, Tae Hyup Kim, Hye Won Park, Jaewon Choe, Jaeil Kim, Han Chu Lee
A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis: HCC prediction for non-cirrhotic NAFLD. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2023)
Gi-Ae Kim, Yewan Park, Shin Ju Oh, Jooyi Jung, Seungbong Han, Hye-Sook Chang, Sung Won Park, Tae Hyup Kim, Hye Won Park, Jaewon Choe, Jaeil Kim, Han Chu Lee
A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis: HCC prediction for non-cirrhotic NAFLD. Liver international : official journal of the International Association for the Study of the Liver (2023)
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jin-Hong Park, Sang Min Yoon
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study. Journal of liver cancer 22 (2) (2022)
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jin-Hong Park, Sang Min Yoon
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study. Journal of liver cancer 22 (2) (2022)
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jin-Hong Park, Sang Min Yoon
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study. Journal of liver cancer 22 (2) (2022)
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jin-Hong Park, Sang Min Yoon
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study. Journal of liver cancer 22 (2) (2022)
Dongsub Jeon, Gi-Won Song, Han Chu Lee, Ju Hyun Shim
Treatment patterns for hepatocellular carcinoma in patients with Child-Pugh class B and their impact on survival: A Korean nationwide registry study. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Jonggi Choi, Jina Park, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Young-Hwa Chung
The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment. Gut and liver 16 (6) (2022)
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma. Journal of liver cancer 22 (1) (2022)
Jihye Lim, Seungbong Han, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Dong Hwan Jung, Sung-Gyu Lee, Ki-Hun Kim, Jonggi Choi
Identification of hepatic steatosis in living liver donors by machine learning models. Hepatology communications 6 (7) (2022)
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma. Journal of liver cancer 22 (1) (2022)
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma. Journal of liver cancer 22 (1) (2022)
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma. Journal of liver cancer 22 (1) (2022)
Jihye Lim, Jung-Bok Lee, Jihyun An, Gi-Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim
Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000-Korean outcome study. Journal of viral hepatitis 29 (9) (2022)
Jihye Lim, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jonggi Choi
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naïve chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver 42 (7) (2022)
Yuri Jeong, Kyung Jin Lee, So Jung Lee, Yong Moon Shin, Min-Ju Kim, Young-Suk Lim, Han Chu Lee, Jinhong Jung, Jin-Hong Park, Jong Hoon Kim, So Yeon Kim, Sang Min Yoon
Radiofrequency ablation versus stereotactic body radiation therapy for small (≤ 3 cm) hepatocellular carcinoma: A retrospective comparison analysis. Journal of gastroenterology and hepatology 36 (7) (2021)
Joon Yeul Nam, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, In Hee Kim, Sung Bum Cho, Han Chu Lee, Si Hyun Bae, Moran Ki, Hwa Young Choi, Eun Young Lee, Sook-Hyang Jeong
Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study. Gut and liver 14 (2) (2021)
Eo-Jin Kim, Changhoon Yoo, Hyo Jeong Kang, Kyu-Pyo Kim, Min-Hee Ryu, Sook Ryun Park, Danbi Lee, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Baek-Yeol Ryoo
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Jihyun An, Deokhoon Kim, Bora Oh, Yoo-Jin Oh, Jihyun Song, Naomi Park, Ha Il Kim, Hyo Jeong Kang, Ji-Hye Oh, Wonkyung Kim, Eunjung Lee, Chang Ohk Sung, Gi-Won Song, Dae-Ghon Kim, Eunsil Yu, Eric Letouzé, Jessica Zucman-Rossi, Han Chu Lee, Ju Hyun Shim
Comprehensive characterization of viral integrations and genomic aberrations in HBV-infected intrahepatic cholangiocarcinomas. Hepatology (Baltimore, Md.) (2021)
Myungsu Lee, Jin Wook Chung, Kwang-Hun Lee, Jong Yun Won, Ho Jong Chun, Han Chu Lee, Jin Hyoung Kim, In Joon Lee, Saebeom Hur, Hyo Cheol Kim, Yun Joon Kim, Gyoung Min Kim, Seung-Moon Joo, Jung Suk Oh
Prospective Multi-Center Korean Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolics for Nodular Hepatocellular Carcinoma: A Two-Year Outcome Analysis. Korean journal of radiology 22 (10) (2021)
Won-Mook Choi, Ji Yoon Kim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Young Suk Lim, Han Chu Lee, Changhoon Yoo, Min-Hee Ryu, Baek-Yeol Ryoo, Kang Mo Kim
Kinetics of the neutrophil-lymphocyte ratio during PD-1 inhibition as a prognostic factor in advanced hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 41 (9) (2021)
Soree Park, Eun-Sook Park, Ja Eun Koo, Yong Kwang Park, Ah Ram Lee, Mehrangiz Dezhbord, Eun Sook Cho, Sung Hyun Ahn, Doo Hyun Kim, Jeong-Hoon Lee, Han Chu Lee, Kyun-Hwan Kim
Entecavir-resistant hepatitis B virus decreases surface antigenicity: A full genome and functional characterization. Liver international : official journal of the International Association for the Study of the Liver 40 (7) (2020)
Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Yung Sang Lee, Han Chu Lee
Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma. PloS one 15 (3) (2020)
Sunmin Park, Jinhong Jung, Byungchul Cho, So Yeon Kim, Sung-Cheol Yun, Young-Suk Lim, Han Chu Lee, Jongmoo Park, Jin-Hong Park, Jong Hoon Kim, Sang Min Yoon
Clinical outcomes of stereotactic body radiation therapy for small hepatocellular carcinoma. Journal of gastroenterology and hepatology 35 (11) (2020)
S Park, J Jung, B Cho, S Y Kim, S-C Yun, Y-S Lim, Han Chu Lee, J Park, J-H Park, J H Kim, Sang Min Yoon
In reply to Huo et al.: Treating small hepatocellular carcinoma: Stereotactic body radiation therapy versus radiofrequency ablation. Journal of gastroenterology and hepatology 35 (12) (2020)
Yeonjung Ha, Tae Hun Kim, Jae Eul Shim, Sunghyun Yoon, Mi Jung Jun, Young-Ho Cho, Han Chu Lee
Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study. Hepatology international 13 (6) (2019)
Seong Kyun Na, Gwang Hyeon Choi, Han Chu Lee, Yong Moon Shin, Jihyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee
The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection. PloS one 13 (6) (2018)